Wenjie Luo

Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer

Ursula A. Matulonis, Gerburg M. Wulf, William T. Barry et al. · Annals of Oncology · 2016 · 208 citations · Full text

Breast Oncology, Inhibitor Olaparib, Medicine +8

Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer

J.F. Liu, William T. Barry, Michael J. Birrer et al. · Annals of Oncology · 2019 · 181 citations · Full text

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer

Wenjie Luo, Jun Wang, Wenhao Xu et al. · Cell Death and Disease · 2021 · 178 citations · Full text

<i>2H</i>‐Azirines: Recent Progress in Synthesis and Applications

Fen Xu, Fan‐Wang Zeng, Wenjie Luo et al. · European Journal of Organic Chemistry · 2024 · 38 citations

Chemical Engineering, Engineering, Heterocyclic +7

Molecular cloning and characterization of antimicrobial peptides from skin of &amp;lt;italic&amp;gt;Hylarana guentheri&amp;lt;/italic&amp;gt;

Zhu Dong, Wenjie Luo, Hengren Zhong et al. · Acta Biochimica et Biophysica Sinica · 2017 · 31 citations · Full text

Microbial Pathogens, Antimicrobial Peptides, Escherichia Coli +19